Willis Johnson & Associates, Inc. Danaher Corp Transaction History

Willis Johnson & Associates, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	SELL	$233.08 - $265.59 $30,067 - $34,261	-129 Reduced 11.07%	1,036 $257,000
Q2 2023 Jul 17, 2023	SELL	$224.99 - $256.14 $34,423 - $39,189	-153 Reduced 11.61%	1,165 $279,000
Q1 2023 Apr 06, 2023	SELL	$239.75 - $277.0 $37,640 - $43,489	-157 Reduced 10.64%	1,318 $332,000
Q4 2022 Jan 20, 2023	SELL	$241.42 - $282.29 $16,175 - $18,913	-67 Reduced 4.35%	1,475 $0
Q3 2022 Oct 12, 2022	SELL	$247.06 - $1507.4 $1,482 - $9,044	-6 Reduced 0.39%	1,542 $398,000
Q2 2022 Jul 18, 2022	SELL	$237.11 - $299.66 $70,895 - $89,598	-299 Reduced 16.19%	1,548 $392,000
Q1 2022 May 10, 2022	BUY	$257.27 - $315.76 $475,177 - $583,208	1,847 New	1,847 $542,000

2,432

563M

3.94M

4.11M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $177B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Willis Johnson & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Willis Johnson & Associates, Inc. with notifications on news.